Exelixis Stock Technical Analysis
| EXEL Stock | USD 41.36 0.92 2.18% |
As of the 31st of January, Exelixis shows the Coefficient Of Variation of 2910.98, downside deviation of 1.9, and Mean Deviation of 1.57. Exelixis technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Exelixis treynor ratio, and the relationship between the standard deviation and downside variance to decide if Exelixis is priced favorably, providing market reflects its regular price of 41.36 per share. Given that Exelixis has jensen alpha of 0.0384, we urge you to verify Exelixis's prevailing market performance to make sure the company can sustain itself at a future point.
Exelixis Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Exelixis, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ExelixisExelixis' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Exelixis Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 45.78 | Buy | 20 | Odds |
Most Exelixis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Exelixis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Exelixis, talking to its executives and customers, or listening to Exelixis conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. Projected growth potential of Exelixis fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Exelixis assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.725 | Earnings Share 2.38 | Revenue Per Share | Quarterly Revenue Growth 0.108 | Return On Assets |
Investors evaluate Exelixis using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Exelixis' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Exelixis' market price to deviate significantly from intrinsic value.
It's important to distinguish between Exelixis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Exelixis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Exelixis' market price signifies the transaction level at which participants voluntarily complete trades.
Exelixis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Exelixis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Exelixis.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in Exelixis on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Exelixis or generate 0.0% return on investment in Exelixis over 90 days. Exelixis is related to or competes with Biomarin Pharmaceutical, Moderna, Revolution Medicines, Bio Techne, Halozyme Therapeutics, Madrigal Pharmaceuticals, and Avidity Biosciences. Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization ... More
Exelixis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Exelixis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Exelixis upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.9 | |||
| Information Ratio | 0.0133 | |||
| Maximum Drawdown | 11.45 | |||
| Value At Risk | (2.93) | |||
| Potential Upside | 4.06 |
Exelixis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Exelixis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Exelixis' standard deviation. In reality, there are many statistical measures that can use Exelixis historical prices to predict the future Exelixis' volatility.| Risk Adjusted Performance | 0.0315 | |||
| Jensen Alpha | 0.0384 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.0149 | |||
| Treynor Ratio | 0.0888 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Exelixis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Exelixis January 31, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0315 | |||
| Market Risk Adjusted Performance | 0.0988 | |||
| Mean Deviation | 1.57 | |||
| Semi Deviation | 1.75 | |||
| Downside Deviation | 1.9 | |||
| Coefficient Of Variation | 2910.98 | |||
| Standard Deviation | 2.13 | |||
| Variance | 4.55 | |||
| Information Ratio | 0.0133 | |||
| Jensen Alpha | 0.0384 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.0149 | |||
| Treynor Ratio | 0.0888 | |||
| Maximum Drawdown | 11.45 | |||
| Value At Risk | (2.93) | |||
| Potential Upside | 4.06 | |||
| Downside Variance | 3.6 | |||
| Semi Variance | 3.05 | |||
| Expected Short fall | (1.74) | |||
| Skewness | 0.5464 | |||
| Kurtosis | 1.14 |
Exelixis Backtested Returns
As of now, Exelixis Stock is very steady. Exelixis secures Sharpe Ratio (or Efficiency) of 0.0724, which denotes the company had a 0.0724 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Exelixis, which you can use to evaluate the volatility of the firm. Please confirm Exelixis' Downside Deviation of 1.9, mean deviation of 1.57, and Coefficient Of Variation of 2910.98 to check if the risk estimate we provide is consistent with the expected return of 0.16%. Exelixis has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.71, which means possible diversification benefits within a given portfolio. As returns on the market increase, Exelixis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Exelixis is expected to be smaller as well. Exelixis right now shows a risk of 2.17%. Please confirm Exelixis downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Exelixis will be following its price patterns.
Auto-correlation | 0.32 |
Below average predictability
Exelixis has below average predictability. Overlapping area represents the amount of predictability between Exelixis time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Exelixis price movement. The serial correlation of 0.32 indicates that nearly 32.0% of current Exelixis price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.32 | |
| Spearman Rank Test | -0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 2.0 |
Exelixis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Exelixis Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Exelixis volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Exelixis Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Exelixis on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Exelixis based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Exelixis price pattern first instead of the macroeconomic environment surrounding Exelixis. By analyzing Exelixis's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Exelixis's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Exelixis specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2026 (projected) | Payables Turnover | 2.18 | 1.77 | 2.15 | 2.26 | Days Of Inventory On Hand | 189.79 | 209.88 | 87.16 | 82.8 |
Exelixis January 31, 2026 Technical Indicators
Most technical analysis of Exelixis help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Exelixis from various momentum indicators to cycle indicators. When you analyze Exelixis charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0315 | |||
| Market Risk Adjusted Performance | 0.0988 | |||
| Mean Deviation | 1.57 | |||
| Semi Deviation | 1.75 | |||
| Downside Deviation | 1.9 | |||
| Coefficient Of Variation | 2910.98 | |||
| Standard Deviation | 2.13 | |||
| Variance | 4.55 | |||
| Information Ratio | 0.0133 | |||
| Jensen Alpha | 0.0384 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.0149 | |||
| Treynor Ratio | 0.0888 | |||
| Maximum Drawdown | 11.45 | |||
| Value At Risk | (2.93) | |||
| Potential Upside | 4.06 | |||
| Downside Variance | 3.6 | |||
| Semi Variance | 3.05 | |||
| Expected Short fall | (1.74) | |||
| Skewness | 0.5464 | |||
| Kurtosis | 1.14 |
Exelixis January 31, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Exelixis stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | (0.53) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 41.63 | ||
| Day Typical Price | 41.54 | ||
| Price Action Indicator | (0.73) | ||
| Market Facilitation Index | 1.74 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. Projected growth potential of Exelixis fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Exelixis assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.725 | Earnings Share 2.38 | Revenue Per Share | Quarterly Revenue Growth 0.108 | Return On Assets |
Investors evaluate Exelixis using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Exelixis' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Exelixis' market price to deviate significantly from intrinsic value.
It's important to distinguish between Exelixis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Exelixis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Exelixis' market price signifies the transaction level at which participants voluntarily complete trades.